Global Liranaftate Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Liranaftate Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Liranaftate is suitable for the topical treatment of cutaneous fungal infections, such as tinea corporis, tinea corporis, tinea corporis, tinea pedis.
Liranaftate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Liranaftate market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Tinea Pedis and Jock Itch are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Liranaftate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Liranaftate key companies include Zhejiang Wansheng Pharmaceutical Co. Ltd, Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd, Tianfang Pharmaceutical Co., Ltd, Yangzijiang Pharmaceutical Group Co. Ltd, Nanjing Changao Pharmaceutical Co. Ltd and Zenyaku Kogyo Company, etc. Zhejiang Wansheng Pharmaceutical Co. Ltd, Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd, Tianfang Pharmaceutical Co., Ltd are top 3 players and held % share in total in 2022.
Liranaftate can be divided into Cream and Spray, etc. Cream is the mainstream product in the market, accounting for % share globally in 2022.
Liranaftate is widely used in various fields, such as Tinea Pedis and Jock Itch, etc. Tinea Pedis provides greatest supports to the Liranaftate industry development. In 2022, global % share of Liranaftate went into Tinea Pedis filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Liranaftate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Zhejiang Wansheng Pharmaceutical Co. Ltd
Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd
Tianfang Pharmaceutical Co., Ltd
Yangzijiang Pharmaceutical Group Co. Ltd
Nanjing Changao Pharmaceutical Co. Ltd
Zenyaku Kogyo Company
Segment by Type
Cream
Spray
Tinea Pedis
Jock Itch
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Liranaftate market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Liranaftate introduction, etc. Liranaftate Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Liranaftate market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Liranaftate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Liranaftate market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Tinea Pedis and Jock Itch are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Liranaftate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Liranaftate key companies include Zhejiang Wansheng Pharmaceutical Co. Ltd, Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd, Tianfang Pharmaceutical Co., Ltd, Yangzijiang Pharmaceutical Group Co. Ltd, Nanjing Changao Pharmaceutical Co. Ltd and Zenyaku Kogyo Company, etc. Zhejiang Wansheng Pharmaceutical Co. Ltd, Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd, Tianfang Pharmaceutical Co., Ltd are top 3 players and held % share in total in 2022.
Liranaftate can be divided into Cream and Spray, etc. Cream is the mainstream product in the market, accounting for % share globally in 2022.
Liranaftate is widely used in various fields, such as Tinea Pedis and Jock Itch, etc. Tinea Pedis provides greatest supports to the Liranaftate industry development. In 2022, global % share of Liranaftate went into Tinea Pedis filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Liranaftate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Zhejiang Wansheng Pharmaceutical Co. Ltd
Fujian Provincial Li Fei Ke Pharmaceutical Co. Ltd
Tianfang Pharmaceutical Co., Ltd
Yangzijiang Pharmaceutical Group Co. Ltd
Nanjing Changao Pharmaceutical Co. Ltd
Zenyaku Kogyo Company
Segment by Type
Cream
Spray
Segment by Application
Tinea Pedis
Jock Itch
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Liranaftate market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Liranaftate introduction, etc. Liranaftate Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Liranaftate market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.